Randomized evidence from clinical trials and naturalistic evidence gathered from pharmacoepidemiology and pharmacovigilance routines both of those lead to your Preliminary and steady assessment of the benefits and risks of a drug, ie, the balance in between therapeutic efficacy and security risks. Benefit-risk assessment (BRA) largely depends on th